BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18297137)

  • 1. Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
    Turner R; Vink R
    Timely Top Med Cardiovasc Dis; 2007 Oct; 11():E24. PubMed ID: 18297137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neurogenic inflammation as a novel treatment for ischemic stroke.
    Turner R; Vink R
    Drug News Perspect; 2007 May; 20(4):221-6. PubMed ID: 17637934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance P in traumatic brain injury.
    Donkin JJ; Turner RJ; Hassan I; Vink R
    Prog Brain Res; 2007; 161():97-109. PubMed ID: 17618972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance P is associated with the development of brain edema and functional deficits after traumatic brain injury.
    Donkin JJ; Nimmo AJ; Cernak I; Blumbergs PC; Vink R
    J Cereb Blood Flow Metab; 2009 Aug; 29(8):1388-98. PubMed ID: 19436311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments.
    Donkin JJ; Vink R
    Curr Opin Neurol; 2010 Jun; 23(3):293-9. PubMed ID: 20168229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats.
    Nimmo AJ; Cernak I; Heath DL; Hu X; Bennett CJ; Vink R
    Neuropeptides; 2004 Feb; 38(1):40-7. PubMed ID: 15003715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of neuropeptides in the lung tissue correlates brain death-induced neurogenic edema.
    Barklin A; Theodorsson E; Tyvold SS; Larsson A; Granfeldt A; Sloth E; Tonnesen E
    J Heart Lung Transplant; 2009 Jul; 28(7):725-32. PubMed ID: 19560702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK1 tachykinin receptor treatment is superior to capsaicin pre-treatment in improving functional outcome following acute ischemic stroke.
    Turner RJ; Vink R
    Neuropeptides; 2014 Oct; 48(5):267-72. PubMed ID: 25151181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P antagonists as a novel intervention for brain edema and raised intracranial pressure.
    Gabrielian L; Helps SC; Thornton E; Turner RJ; Leonard AV; Vink R
    Acta Neurochir Suppl; 2013; 118():201-4. PubMed ID: 23564132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.
    Sorby-Adams AJ; Marcoionni AM; Dempsey ER; Woenig JA; Turner RJ
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28817088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recanalization and reperfusion therapies for acute ischemic stroke.
    Molina CA; Alvarez-Sabín J
    Cerebrovasc Dis; 2009; 27 Suppl 1():162-7. PubMed ID: 19342847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation.
    Seegers HC; Hood VC; Kidd BL; Cruwys SC; Walsh DA
    J Pharmacol Exp Ther; 2003 Jul; 306(1):8-12. PubMed ID: 12660314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased pain and neurogenic inflammation in mice deficient of neutral endopeptidase.
    Krämer HH; He L; Lu B; Birklein F; Sommer C
    Neurobiol Dis; 2009 Aug; 35(2):177-83. PubMed ID: 19084065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurogenic inflammation in acute pancreatitis.
    Hegde A; Bhatia M
    JOP; 2005 Sep; 6(5):417-21. PubMed ID: 16186661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury.
    Vink R; van den Heuvel C
    Neurotherapeutics; 2010 Jan; 7(1):74-80. PubMed ID: 20129499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance P as a mediator of neurogenic inflammation after balloon compression induced spinal cord injury.
    Leonard AV; Thornton E; Vink R
    J Neurotrauma; 2013 Nov; 30(21):1812-23. PubMed ID: 23924052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin B2 receptor antagonism: a new direction for acute stroke therapy?
    Sobey CG
    Br J Pharmacol; 2003 Aug; 139(8):1369-71. PubMed ID: 12922922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurogenic mechanisms in bronchial inflammatory diseases.
    Groneberg DA; Quarcoo D; Frossard N; Fischer A
    Allergy; 2004 Nov; 59(11):1139-52. PubMed ID: 15461593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposing roles for reactive astrocytes following traumatic brain injury.
    Laird MD; Vender JR; Dhandapani KM
    Neurosignals; 2008; 16(2-3):154-64. PubMed ID: 18253055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.